PDF(3041 KB)
Technical points and difficulties of robotic-assisted surgery for hepatic hemangioma
JIN Ren-an, LIANG Xiao
Chinese Journal of Practical Surgery ›› 2026, Vol. 46 ›› Issue (3) : 323-326.
PDF(3041 KB)
PDF(3041 KB)
Technical points and difficulties of robotic-assisted surgery for hepatic hemangioma
Robotic-assisted hepatectomy has the advantages of being minimally invasive, precise, and controllable in the treatment of giant hepatic hemangiomas, performing particularly well in high-risk vascular anatomy and deep tumor localization. Due to their rich blood supply, massive size, and complex locations, hepatic hemangiomas often pose many technical challenges during surgery, including massive intraoperative bleeding, injury to the hepatic vein or inferior vena cava, and preservation of liver function. Preoperatively, three-dimensional visualization technology is used to obtain precise anatomical information to guide preoperative planning. Intraoperatively, appropriate body positioning and trocar layout are selected. Techniques such as feeding vessel occlusion and hepatic inflow occlusion are comprehensively utilized to effectively control bleeding. Based on the tumor’s location, size, and relationship with major blood vessels, enucleation or anatomical resection is reasonably selected. Combined with the improvement of the surgical approach and intraoperative indocyanine green (ICG) navigation, efforts are made to safely and precisely resect the hepatic hemangioma while maximizing the preservation of normal liver parenchyma.
robotic hepatectomy / hepatic hemangioma / three-dimensional visualization / blood flow occlusion / fluorescence navigation
| [1] |
|
| [2] |
The technical advantages of robotic platforms may facilitate minimally invasive liver resections, improving outcomes over the laparoscopic approach. This meta-analysis aimed to compare outcomes of robotic liver resection (RLR) versus laparoscopic liver resection (LLR).A systematic literature search identified matched cohort studies and randomized controlled trials comparing RLR and LLR from 2003 to 2024. Studies concerning transplant hepatectomy and retrospective studies with fewer than 50 patients per group were excluded. Perioperative outcomes were analyzed in a meta-analysis, with subgroup analyses for minor anterolateral (AL), minor posterosuperior (PS), and major resections.Overall, 31 studies with 8989 patients undergoing RLR and 43 474 LLR were included, with 8207 RLRs and 9763 LLRs after matching. RLR was associated with lower conversion (RR 0.41 [95% CI, 0.32-0.52]), overall morbidity (RR 0.92 [95% CI, 0.84-1.00]), and severe morbidity rate (RR 0.81 [95% CI, 0.70-0.94]), as well as higher rates of R0 resection (RR 1.02 [95% CI, 1.01-1.03]) and readmission (RR 1.24 [95% CI, 1.09-1.41]). There were no significant differences in blood loss, transfusion, Pringle use, operative time, hospital stay, and mortality. RLR reduced blood loss in minor AL and PS resections, with fewer transfusions also observed in minor AL. RLR was associated with shorter hospital stays in minor PS resections. Notably, RLR was associated with less overall morbidity in minor AL and less severe morbidity in major resections. Available results on long-term oncological outcomes were not suitable for meta-analysis.RLR demonstrates advantages in several key perioperative outcomes compared to LLR across the full spectrum of liver resection complexity.Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
|
| [3] |
Minimally invasive techniques have increasingly been adopted for liver resection. This study aimed to compare the perioperative outcomes of robot-assisted liver resection (RALR) with laparoscopic liver resection (LLR) for liver cavernous hemangioma and to evaluate the treatment feasibility and safety.
|
| [4] |
|
| [5] |
Hepatectomy is particularly difficult when the tumor is large, close to the inferior vena cava or the main trunk of the hepatic or portal vein, or in the caudate lobe, as well as when the operation is a re-hepatectomy, because two-dimensional computed tomography (CT) often does not clearly show tumor location relative to blood vessels.To evaluate the efficacy of three-dimensional computed tomography (3D-CT), reconstructed from multidetector-row computed tomography (MD-CT) with contrast, MD-CT was performed in 17 patients before hepatectomy.The third-order branches of the hepatic artery and the portal vein were clearly shown in all cases. Both the hepatic vein, which drained the same segment that the portal vein fed, and the portal vein were also clearly shown. These vessels could be visualized from any perspective. In 2 patients who underwent hemihepatectomy, large tumors (23.0 and 17.0 cm) displaced the vasculature, but the positions of tumor and vessels could be precisely evaluated by 3D-CT. In patients who required replacement of the vena cava with synthetic grafts, the distance and direction of pressure to IVC by tumor was accurately estimated by 3D-CT. In patients who were limited to segmentectomy or partial hepatectomy because of prior hepatectomy or tumor position, evaluation of the glissons was facilitated by 3D-CT.Three-dimensional-CT was extremely useful for preoperative simulation because it provided important information that could not be obtained with 2D-CT.
|
| [6] |
Hepatic hemangioma (HH) is the most common benign solid tumor of the liver. The aim of this study is to review our experiences of surgical treatment for giant HH and to show the impact of HH size and type of surgical resection on surgical outcomes.This is a retrospective study of the cases who underwent surgery for giant HH during the period from January 2000 to April 2017.Elective surgery was performed for 144 patients who had giant HH. The median diameter of resected HH was 10 cm (5-31 cm). Enucleation was performed for 92 (63.9%) patients and anatomical resection was required in 52 (36.1%) patients. No statistical difference between enucleation and resection as regards intraoperative and postoperative findings. The amount of intraoperative blood loss is significantly more in HH > 10 cm (300 vs. 575 ml, P = 0.007), the need of blood transfusion was significantly more in HH > 10 cm (P = 0.000), and the operation time was significantly longer in HH > 10 cm (120 vs. 180 min, P = 0.000). The size of HH had no significant effect as regards the development of postoperative complications.Giant hemangioma can be treated surgically with low incidence of morbidity and mortality. No statistical difference between enucleation and resection as regards surgical outcomes. In left lobe HH, HH located deeper in posterior hepatic segments and in multiple HH, hepatic resection is preferred. The size of the HH had significant impact intraoperative blood loss and operative time.
|
| [7] |
|
| [8] |
The management of symptomatic giant hepatic hemangiomas (> 10 cm) varies in the literature. Multiple interventional approaches have been described including surveillance, embolization, enucleation, and resection based on tumor size, location, relationship to vascular and biliary structures, and the quality and quantity of the functional liver remnant. Resection is often performed as a last resort due to the risk of major hemorrhage. Preoperative arterial embolization is an option; however, many patients will experience severe pain, fever, transaminitis, acidosis, recanalization, and collateral inflow that limit its utility. Furthermore, patients require post-procedure inpatient observation, and there is no consensus on the appropriate time interval between procedures. We present and demonstrate a technique in the video that utilizes a hybrid operating room with on-table angiogram capabilities to perform hemangioma inflow embolization and immediate hepatic resection under the same anesthesia in a single procedure. Combining on-table embolization with immediate resection avoids many of the pitfalls of preoperative embolization, while enhancing the safety of the resection by decreasing the size of the tumor, enabling compressibility, and facilitating exposure of the vascular inflow and outflow. It is an efficient use of hospital resources and eliminates an intervening hospital admission. We have found it to be a preferred approach to enhance the safety and feasibility of resection for massive hepatic hemangiomas with minimal intraoperative blood loss and reduced risk.
|
| [9] |
<b><i>Background:</i></b> Hepatic hemangiomas are the most common benign liver tumors, and the management of giant hepatic hemangioma (GHH) is still in controversial. The aim of this meta-analysis was to compare the postoperative outcomes of enucleation versus anatomic resection for GHH. <b><i>Methods:</i></b> PubMed, Embase, Web of Science, and the Cochrane Library were searched from January 1988 to December 2015 to identify studies comparing the outcomes of enucleation versus anatomic resection for GHH. Finally, we performed this meta-analysis using the Review Manager 5.3 software, and the results were presented as risk ratio (RR) or mean difference (MD) with corresponding 95% confidence interval (CI). The major limitation is that all data were derived from nonrandomized studies, and we cannot exclude potential selection bias. <b><i>Results:</i></b> Nine studies involving 1,185 patients were included. The results showed that there was a lower incidence of complications (RR = 0.66, 95% CI 0.52 to 0.84, <i>I</i><sup>2</sup> = 0%, <i>p</i> = 0.0007); no incidents of death occurred among the 9 included trials. Blood loss (MD = -419.07 mL, 95% CI -575.04 to -263.09, <i>I</i><sup>2</sup> = 83%, <i>p</i> < 0.00001), duration of surgery (MD = -23.5 min, 95% CI -45.28 to -1.74, <i>I</i><sup>2</sup> = 0%, <i>p</i> = 0.03), and length of hospital stay (MD = -1.59 days, 95% CI -3.06 to -0.13, <i>I</i><sup>2</sup> = 0%, <i>p</i> = 0.03) were much lower in the enucleation group. <b><i>Conclusions:</i></b> GHH can be removed safely by either enucleation or anatomic resection. Enucleation can preserve more hepatic parenchyma and reduce postoperative complications, which is why it should be the preferred surgical procedure for suitable lesions.
|
| [10] |
Liver hemangiomas are benign liver lesions that require surgical excision when large and symptomatic. Often, these tumors are removed through large anatomical resections which sacrifice more liver parenchyma than needed. Tumor enucleation, which takes advantage of a digitoclasia-like technique along the plane between the tumor pseudo-capsule and liver parenchyma, poses challenges when performed laparoscopically. We propose a parenchymal sparing, minimally invasive, robotic-assisted technique to remove liver hemangiomas.
|
| [11] |
|
| [12] |
|
| [13] |
Resection of the hemangioma located in the caudate lobe is a major challenge in current liver surgery. This study aimed to present our surgical technique for this condition. Two consecutive patients with symptomatic hepatic hemangioma undergoing caudate lobectomy were investigated retrospectively. First, all the blood inflow of hemangioma from the portal vein and the hepatic artery at the base of the umbilical fissure was dissected. After the tumors became soft and tender, the short hepatic veins and the ligaments between the secondary porta hepatis were severed. At last the tumors were resected from the right lobe of the liver. The whole process was finished by a left-sided approach. Blood lost in Case 1 was 1650 mL because of ligature failing in one short hepatic vein, and in the other case, 210 mL. Operation time was 236 minutes and 130 minutes, respectively. Postoperative hospital stays were 11 and 5 days, respectively. The diameter of tumors was 9.0 cm and 6.5 cm. Case 1 required blood transfusion during surgery. No complications such as biliary fistula, postoperative bleeding, and liver failure occurred. The left-sided approach produced the best results for caudate lobe resection in our cases. The patients who recovered are living well and asymptomatic. Caudate lobectomy can be performed safely and quickly by a left-sided approach, which is carried out with optimized perioperative management and innovative surgical technique.
|
| [14] |
|
| [15] |
|
利益冲突 所有作者均声明不存在利益冲突
/
| 〈 |
|
〉 |